Currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of care.

• Granted FDA Breakthrough Device Designation for products that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions
• In vivo animal and in vitro lab studies demonstrated up to 99.6% effectiveness in killing biofilms, including drug-resistant bacteria such as MRSA, E. Coli, etc.
• May help retain the original implant
• BioPrax is easy to use – requires minimal training
• Minimally invasive procedure

Implant Bacterial Biofilm Infections - a Transformational Treatment